NANOPEC Development of a Nanohybrid System Based Wearable Microfluidic Photoelectrochemical Sensor for the On-demand Ctni Detection (nanopec)
- Coordinator
- Kauno Technologijos Universitetas, Lithuania
- Runs
- 1 February 2027 to 31 January 2029
- Status
- Running
- EU funding
- €197k
- Total cost
- —
- Partners
- 3 organisations in 3 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101278160
What the project is doing
In the project's own words, from its summary on CORDIS.
Development of a Nanohybrid System Based Wearable Microfluidic Photoelectrochemical Sensor for the On-Demand cTnI DetectionThe Acute Myocardial Infarction (AMI) demands instant diagnosis, since the currently existing technologies remain invasive, expensive, time-consuming, and confined to clinical setups. The project NANOPEC proposed for the MSCA PF application hosts an innovative solution with the development of a wearable, biorecognition-free, microfluidic photoelectrochemical (PEC) saliva sensor for the ultrasensitive detection of cardiac troponin (cTnI).
Fundamentally, it lies in a unique zinc oxide tetrapod-graphene quantum dot (ZnOTPD/GQD)-based nanohybrid system, while GQD will be derived sustainably from plastic waste. Embedding this into a flexible, wearable patch will enable the on-demand real-time monitoring of cTnI levels. This project relies on the following key deliverables: Development of GQD with quantum yield > 50% with photoinduced charge transfer efficiency over 85% within the nanohybrid, Fabrication of a durable, microfluidic PEC patch withstanding at least 50 cycles while keeping a stable performance, ultrasensitive detection with an expected limit of detection < 5 pg/ml, and validation of the sensor performance with artificial saliva matrices with reproducibility (expected RSD under 8%) and robustness against common interfering analytes.
By interlinking nanotechnology, material science, and wearable diagnostics, NANOPEC will open up a way for a low-cost, scalable, sustainable, non-invasive, on-set diagnostic tool, which will improve clinical outcomes and reduce the global mortality rate.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Kauno Technologijos Universitetas | Kaunas | Lithuania | Coordinator |
| Universite Paris Cite | Paris | France | Associatedpartner |
| Uniwersytet Im. Adama Mickiewicza Wpoznaniu | Poznan | Poland | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI